Parker Laboratories Helix CBD Therapy Cream Menthol Recall

Why it was recalled

CGMP Deviations

Product description

Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004

Lot numbers, UPCs & expiration codes

Lot #: a) J1121010, Exp. Date 12/16/2023, b) A0921006, Exp. Date 8/16/2023, c) A0921007, Exp. Date 8/16/2023

Where it was sold

Nationwide within the United States, Singapore, Korea and Hong Kong

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1092-2023
Classification: Class II
Status: Terminated
Recall initiated: Aug 2, 2023
FDA report date: Aug 30, 2023
Quantity: 40
Recall type: Voluntary: Firm initiated
Recalling firm: Parker Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1092-2023, exactly as published.

Show all FDA fields

City: Fairfield
State: NJ
Status: Terminated
Country: United States
Event ID: 92786
Address: 286 Eldridge Rd
Code information: Lot #: a) J1121010, Exp. Date 12/16/2023, b) A0921006, Exp. Date 8/16/2023, c) A0921007, Exp. Date 8/16/2023
Postal code: 07004-2509
Report date: Aug 30, 2023
Product type: Drugs
Recall number: D-1092-2023
Classification: Class II
Recalling firm: Parker Laboratories, Inc.
Product quantity: 40
Termination date: Jun 3, 2024
Reason for recall: CGMP Deviations
Voluntary / mandated: Voluntary: Firm initiated
Product description: Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004
Distribution pattern: Nationwide within the United States, Singapore, Korea and Hong Kong
Recall initiation date: Aug 2, 2023
Initial firm notification: E-Mail
Center classification date: Aug 18, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1092-2023, published Aug 30, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Parker Laboratories Helix CBD Therapy Cream Recall

Summary